GSK's RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18-49 Years at Increased Risk
Forbion Announces Second Exit from Forbion Growth Fund III Following $2.2 Billion Acquisition of RAPT Therapeutics by GSK
PIVOT-PO Phase 3 Data Show Tebipenem HBr's Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections
New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level
Multiple Myeloma Research Foundation Unites Patients and Advocates to Hike New Hampshire's White Mountains to Accelerate a Cure for Multiple Myeloma
QIMC Intersects Major Fault Breccia System in DDH-26-03 at West Advocate and Reports Elevated Hydrogen 2.5 km from the Initial Discovery
Copper Intelligence announces Acquisition of the Kitungu Project - PR 15880 - in the Democratic Republic of Congo copper belt
Harvest Gold Provides Comprehensive Update: Rosebud Project , Mosseau Agreement With Vior, And Eight-Month Progress Report On Urban Barry Belt Properties
NEW QUEBEC GRAPHITE TRANSFORMATION STUDY FOR LAC CARHEIL PROJECT DELIVERS IMPRESSIVE ECONOMIC RESULTS
Canada One Announces 2026 Two-Phase Exploration Program to Advance High-Priority Porphyry Targets at Copper Dome
